New CF Drug's impact on exercise breathing under the microscope
NCT ID NCT07314229
First seen Jan 11, 2026 · Last updated Apr 28, 2026 · Updated 15 times
Summary
This study is for adults with cystic fibrosis who are already taking the medication ETI. Researchers want to find out how many of them have trouble breathing during exercise, even with the drug. Participants will do a 6-minute walk test and a step test while wearing a portable breathing monitor. The goal is to learn more about how well the lungs work during physical activity in people on this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.